ULURU Inc. (NYSE AMEX: ULU) announced today that an Australian Register of Therapeutic Goods Certificate has been issued by the Therapeutic Goods Administration approving the marketing of Altrazeal® in Australia. Kerry P. Gray, President and CEO of ULURU, commented: This is another important milestone in the worldwide commercialization of Altrazeal®. Strategically this is an important […]